Thor Life Science Consulting AB Information

Thor Life Science Consulting provides professional business development support and advice to life science companies, primarily in the pharmaceutical and biotech sectors. Our deal-making experience covers Europe, the US and Asia and includes a wide range of deal structures, therapeutic areas and technologies. Proper planning and implementation of licensing and partnering strategies are key to exploiting the full commercial value of your company’s assets. TLSC provides support in areas such as: - Licensing strategy development - Building the business case - Establishing competitive deal processes - Preparation of presentation material and Information Memorandum - Partner candidate selection - Screening for strategic in-licensing or M&A opportunities - Financial valuation - Due Diligence support - Term sheet drafting and negotiations - Contract negotiations We provide an excellent global network among licensing executives within big pharma, mid-sized pharma and biotech companies as well as corporate venture and VC firms. We have experience from negotiating and closing a number of international licensing deals (preclinical, clinical, in-licensing, out-licensing, option deals, etc.) in Europe, US and Asia. Experience from a wide range of deal types: - In-licensing - Out-licensing - FTO licenses - Mergers & Acquisitions - Co-development - Co-promotion - Research collaborations - Option agreements - Service agreements - Etc. Experience from a range of therapeutic areas: - Oncology - Ophthalmology - Metabolic diseases - Inflammation - Pain - Infectious disease - Etc. Experience from a range of technologies: - Small molecules - Biologics - Cell therapies - Vaccines - Nanotechnology - Diagnostics